Insider Transactions in Q2 2024 at Marinus Pharmaceuticals, Inc. (MRNS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2024
|
Marvin Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+14.02%
|
-
|
|
Jun 18
2024
|
Sara Nochur |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+14.79%
|
-
|
|
Jun 18
2024
|
Timothy M Mayleben |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+8.62%
|
-
|
|
Jun 18
2024
|
Sarah B. Noonberg |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+14.02%
|
-
|
|
Jun 18
2024
|
Christine Berni Silverstein |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+14.02%
|
-
|
|
Jun 18
2024
|
Scott Braunstein CHAIRMAN AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
37,300
+10.71%
|
-
|
|
Jun 18
2024
|
Steven Pfanstiel CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
12,733
+13.1%
|
-
|
|
Jun 18
2024
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,918
+12.34%
|
-
|
|
Jun 18
2024
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
BUY
Grant, award, or other acquisition
|
Direct |
10,918
+14.6%
|
-
|
|
Jun 18
2024
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,918
+13.29%
|
-
|
|
Jun 18
2024
|
Charles Austin |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+15.89%
|
-
|
|
Jun 18
2024
|
Elan Ezickson |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+15.54%
|
-
|
|
Jun 18
2024
|
Seth H. Z. Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+15.11%
|
-
|